Trial Profile
Clinical Trials Insight: 700044006
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Jun 2011
Price :
$35
*
At a glance
- Drugs DM 83 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors DiaMedica
- 01 May 2009 New trial record.
- 14 Jul 2008 Primary endpoint 'Postprandial insulin level' has been met.
- 14 Jul 2008 Primary endpoint 'Postprandial glucose level' has been met.